Carcinoma of unknown primary: 35 years of a single institution's experience

R. Mahmood, M. Aldehaim, F. Hussain, T. Elhassan, Z. A. Khan, M. Memon
{"title":"Carcinoma of unknown primary: 35 years of a single institution's experience","authors":"R. Mahmood, M. Aldehaim, F. Hussain, T. Elhassan, Z. A. Khan, M. Memon","doi":"10.4103/2395-3977.189304","DOIUrl":null,"url":null,"abstract":"Aim: To assess the incidence and characteristics of carcinoma of unknown primary (CUP). Methods: We retrospectively collected the clinical data of CUP cases treated in our medical center between 1975 and 2010, the results of which were statistically analyzed. Further, a comprehensive literature search, using PubMed database, on CUP cases was performed, and the results were discussed. Results: A total of 1250 cases were identified, with male to female ratio of 1.2:1. Median age at diagnosis was 56 ± 16 years. Liver was the most common site of metastasis, followed by neck and peritoneum. Majority of cases (54.5%) received supportive treatment only, with the overall survival, over 1 year period, being 49%. Univariate analysis revealed pathology, gender, and site of disease as the significant predictors of survival, whereas pathology failed to reach significance on multivariate analysis, with “lymph nodes only” carrying the best prognosis. Conclusion: Our data confirm the heterogeneity of CUP cases and variable treatment courses. This highlights the importance of establishing a national registry for this subgroup of cancer patients. Moreover, there is a need to develop multidisciplinary specialist teams and protocols to manage this group of patients, and participation in clinical trials should be strongly encouraged.","PeriodicalId":9428,"journal":{"name":"Cancer Translational Medicine","volume":"32 1","pages":"113 - 118"},"PeriodicalIF":0.0000,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Translational Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/2395-3977.189304","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Aim: To assess the incidence and characteristics of carcinoma of unknown primary (CUP). Methods: We retrospectively collected the clinical data of CUP cases treated in our medical center between 1975 and 2010, the results of which were statistically analyzed. Further, a comprehensive literature search, using PubMed database, on CUP cases was performed, and the results were discussed. Results: A total of 1250 cases were identified, with male to female ratio of 1.2:1. Median age at diagnosis was 56 ± 16 years. Liver was the most common site of metastasis, followed by neck and peritoneum. Majority of cases (54.5%) received supportive treatment only, with the overall survival, over 1 year period, being 49%. Univariate analysis revealed pathology, gender, and site of disease as the significant predictors of survival, whereas pathology failed to reach significance on multivariate analysis, with “lymph nodes only” carrying the best prognosis. Conclusion: Our data confirm the heterogeneity of CUP cases and variable treatment courses. This highlights the importance of establishing a national registry for this subgroup of cancer patients. Moreover, there is a need to develop multidisciplinary specialist teams and protocols to manage this group of patients, and participation in clinical trials should be strongly encouraged.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
原发不明的癌:单一机构35年的经验
目的:探讨不明原发癌(CUP)的发生率及特点。方法:回顾性收集我院1975 ~ 2010年收治的CUP患者的临床资料,对其结果进行统计分析。此外,使用PubMed数据库对CUP病例进行了全面的文献检索,并对结果进行了讨论。结果:共检出1250例,男女比例为1.2:1。诊断时的中位年龄为56±16岁。肝脏是最常见的转移部位,其次是颈部和腹膜。大多数病例(54.5%)仅接受支持性治疗,1年以上总生存率为49%。单因素分析显示病理、性别和疾病部位是生存的重要预测因素,而多因素分析显示病理未达到显著性,“仅淋巴结”预后最好。结论:我们的数据证实了CUP病例和不同疗程的异质性。这突出了为这一癌症患者亚群建立国家登记处的重要性。此外,有必要发展多学科专家团队和方案来管理这组患者,并应大力鼓励参与临床试验。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Cyclooxygenase-2 contributes to mutant epidermal growth factor receptor lung tumorigenesis by promoting an immunosuppressive environment Comparison of histopathological grading and staging of breast cancer with p53-positive and transforming growth factor-beta receptor 2-negative immunohistochemical marker expression cases Characteristics and outcome of patients with pheochromocytoma Chemical compositions and antiproliferative effect of essential oil of asafoetida on MCF7 human breast cancer cell line and female wistar rats Protein disulfide isomerase A3: A potential regulatory factor of colon epithelial cells
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1